Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04784728 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure
A Phase 1 study, sponsored by Scilex Pharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 24
- Enrollment target
NCT04784728 is a Phase 1 study that has completed, run by Scilex Pharmaceuticals. The registered enrollment target is 24 participants.
The verdict
NCT04784728, a Phase 1 study, has completed, sponsored by Scilex Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 24 participants
- Enrollment target
Study Summary
The objectives of this study are to evaluate the adhesion performance and pharmacokinetics of ZTlido (lidocaine topical system) 1.8% during swimming, showering, and under normal conditions.
Interventions
- DRUG Lidocaine topical system 1.8%
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2019-08-21 |
| Est. Completion | 2019-08-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04784728
The ClinicalTrials.gov registry entry for NCT04784728 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scilex Pharmaceuticals, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lidocaine topical system 1.8% is the first listed.
NCT04784728 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04784728 about?
NCT04784728 is a clinical study titled "Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure". The objectives of this study are to evaluate the adhesion performance and pharmacokinetics of ZTlido (lidocaine topical system) 1.8% during swimming, showering, and under normal conditions.
What is the current status of trial NCT04784728?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 24 participants. The study started on 2019-08-21. Estimated completion is 2019-08-31.
What interventions are being tested in trial NCT04784728?
The interventions under investigation include: Lidocaine topical system 1.8% (DRUG).
Who is sponsoring clinical trial NCT04784728?
This trial is sponsored by Scilex Pharmaceuticals, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.